San Diego, California–(Newsfile Corp. – July 28, 2021) – Robbins Geller Rudman & Dowd LLP announces the filing of the Athira Pharma course action lawsuit,
Tag: Pharma
Buyers With Substantial Losses Have Opportunity to Guide the Athira Pharma, Inc. Class Action Lawsuit
SAN DIEGO, July 20, 2021–(Organization WIRE)–Robbins Geller Rudman & Dowd LLP announces that purchasers of Athira Pharma, Inc. (NASDAQ: ATHA) securities involving September 18, 2020
Robbins Geller Rudman & Dowd LLP Announces Chance for Traders with Significant Losses to Lead the Athira Pharma, Inc. Course Action Lawsuit
SAN DIEGO, July 16, 2021 (Globe NEWSWIRE) — The Athira Pharma class motion lawsuit fees Athira Pharma, Inc. (NASDAQ: ATHA) and its CEO with violations
Shareholders With Considerable Losses Have Prospect to Lead the Athira Pharma, Inc. Class Action Lawsuit
San Diego, California–(Newsfile Corp. – July 15, 2021) – The Athira Pharma course action lawsuit rates Athira Pharma, Inc. (NASDAQ: ATHA) and its CEO with
Buyers With Considerable Losses Have Option to Guide the Athira Pharma, Inc. Class Action Lawsuit
SAN DIEGO, July 14, 2021–(Business enterprise WIRE)–Robbins Geller Rudman & Dowd LLP announces that purchasers of Athira Pharma, Inc. (NASDAQ: ATHA) securities amongst September 18,
ATHIRA PHARMA Trader Recognize: Buyers With Substantial Losses Have Possibility to Lead the Athira Pharma, Inc. Class Motion Lawsuit
SAN DIEGO, July 13, 2021 /PRNewswire/ — The Athira Pharma, Inc. course action lawsuit fees Athira Pharma and its CEO with violations of the Securities
Global Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight Report 2021-2026 Featuring Acopedia, Takeda Pharma, TC Biopharma and Adapate Therapeutics
Dublin, May 20, 2021 (GLOBE NEWSWIRE) — The “Global Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026” report has been added
Innate Pharma Announces Conference Simply call and Webcast for 2021 Initial Quarter Company Update
Marseille, France, May perhaps 04, 2021 (Globe NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421 Nasdaq: IPHA) (“Innate” or the “Corporation”), now
Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession
Bloomberg Central Banks to Pour Money Into Economy Despite Sharp Rebound (Bloomberg) — The aggressive rebound in global economic growth still isn’t enough for most
GC Pharma Lights Up to Rejoice ‘World Hemophilia Day’ | Business & Finance
YONGIN, South Korea–(Business enterprise WIRE)–Apr 17, 2021– GC Pharma (previously identified as Inexperienced Cross Corporation), a South Korean biopharmaceutical enterprise, participates in a campaign to